Synlait Plans $130 Million Loan Replacement as Senior Facility Refinancing Nears
Synlait Milk is on track to refinance its senior bank facilities by June 30, 2026, replacing a $130 million shareholder loan from Bright Dairy with a new two-year loan. The company reported a preliminary net loss of $12 million for the first four months of 2026, reflecting operational headwinds and the recent North Island asset sale.
- Progressing refinancing of senior syndicated bank facilities due June 2026
- Replacing $130 million Bright Dairy shareholder loan with similar terms but two-year fixed term
- Replacement loan subordinated and secured second-ranking behind senior facilities
- Preliminary net loss after tax of $12 million for Jan-Apr 2026
- North Island asset sale contributed a preliminary gain during the period
Refinancing on Track with Replacement Shareholder Loan
Synlait Milk Limited (NZX:SML, ASX:SM1) is progressing steadily towards refinancing its senior syndicated bank facilities, which mature on 30 June 2026. Central to this refinancing is the replacement of the $130 million shareholder loan provided by Bright Dairy International Investment Limited in July 2024 with a new loan on substantially similar terms but with a fixed two-year term and adjusted interest margins.
The Replacement Bright Loan retains its subordinated status behind the senior facilities and continues to be secured on a second-ranking basis. Notably, the loan’s interest rate will track the 3-month Bank Bill Benchmark Rate (BKBM) plus a margin aligned with the weighted average margin payable on the senior facilities, resetting upon any refinancing in 2027. The new loan removes legacy provisions no longer applicable and excludes any financial covenants favoring Bright, consistent with the existing loan.
Independent Oversight and Arm’s-Length Negotiations
Synlait has appointed an independent directors’ committee (IDC) to negotiate the Replacement Bright Loan terms, ensuring arm’s-length dealings. The IDC, chaired by independent director George Adams and including Katherine Turner since May 2026, excluded Bright-nominated directors and used separate legal advisors for each party. This governance structure underscores Synlait’s commitment to transparency and independent oversight in refinancing negotiations.
Trading Update Reveals Net Loss and Asset Sale Impact
For the four months ending 30 April 2026, Synlait reported a preliminary net loss after tax of NZ$12.0 million and net assets of NZ$720.8 million. The company attributes much of the negative financial impact to January 2026, amid ongoing operational headwinds previously disclosed in its half-year results. The reported figures also include a preliminary gain from the successful sale of Synlait's North Island assets during this period.
This trading update is based on unaudited management accounts and covers a period with no directly comparable prior data. Synlait plans to release its full audited consolidated results for the financial year ending 31 July 2026 in due course.
Conditions and Next Steps for Refinancing Completion
The Replacement Bright Loan is expected to become effective on 30 June 2026, contingent on approvals from Synlait’s lending group, the IDC, the new senior facilities lenders, and relevant regulatory waivers under NZX Listing Rules. The loan’s proceeds will be used exclusively to repay or prepay Synlait’s and its guarantors’ debts. Synlait is also permitted to prepay the loan early without penalty, subject to senior lender consent and certain financial milestones.
Acting CEO Leon Fung and non-IDC directors have been excluded from the Replacement Bright Loan negotiations to maintain independence, following the recent leadership transition announced in May 2026. This refinancing effort comes as Synlait navigates persistent supply chain challenges and market volatility in the dairy sector.
Bottom Line?
Synlait’s refinancing progress and shareholder loan replacement signal cautious balance sheet management amid early-year losses, but final outcomes hinge on lender approvals and market conditions.
Questions in the middle?
- Will the refinancing terms materially improve Synlait’s credit profile or cost of capital?
- How will the two-year fixed term on the Replacement Bright Loan affect Synlait’s liquidity strategy beyond 2026?
- Can operational improvements offset the early 2026 losses and stabilize earnings by year-end?